Abstract
Escitalopram is a selective serotonin reuptake inhibitor antidepressant approved by the Food and Drug Administration for the treatment of major depressive disorder and generalized anxiety disorder. A 34-year-old female patient with major depressive disorder developed amenorrhea and had a false-positive urine pregnancy test after initiation of escitalopram treatment. To our knowledge, no published case report of amenorrhea and false-positive urine pregnancy tests in women taking escitalopram exists. This case report suggests that women of child-bearing age should be carefully monitored for amenorrhea while they are on an antidepressant treatment regimen.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 40-42 |
| Number of pages | 3 |
| Journal | Korean Journal of Family Medicine |
| Volume | 38 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 1 2017 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Family Practice
Cite this
Escitalopram-induced amenorrhea and false positive urine pregnancy test. / Selvaraj, Vidhya; Hour, Siv; Gunasekar, Palanikumar; Gray, Caron; Smith, James F.
In: Korean Journal of Family Medicine, Vol. 38, No. 1, 01.01.2017, p. 40-42.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Escitalopram-induced amenorrhea and false positive urine pregnancy test
AU - Selvaraj, Vidhya
AU - Hour, Siv
AU - Gunasekar, Palanikumar
AU - Gray, Caron
AU - Smith, James F.
PY - 2017/1/1
Y1 - 2017/1/1
N2 - Escitalopram is a selective serotonin reuptake inhibitor antidepressant approved by the Food and Drug Administration for the treatment of major depressive disorder and generalized anxiety disorder. A 34-year-old female patient with major depressive disorder developed amenorrhea and had a false-positive urine pregnancy test after initiation of escitalopram treatment. To our knowledge, no published case report of amenorrhea and false-positive urine pregnancy tests in women taking escitalopram exists. This case report suggests that women of child-bearing age should be carefully monitored for amenorrhea while they are on an antidepressant treatment regimen.
AB - Escitalopram is a selective serotonin reuptake inhibitor antidepressant approved by the Food and Drug Administration for the treatment of major depressive disorder and generalized anxiety disorder. A 34-year-old female patient with major depressive disorder developed amenorrhea and had a false-positive urine pregnancy test after initiation of escitalopram treatment. To our knowledge, no published case report of amenorrhea and false-positive urine pregnancy tests in women taking escitalopram exists. This case report suggests that women of child-bearing age should be carefully monitored for amenorrhea while they are on an antidepressant treatment regimen.
UR - http://www.scopus.com/inward/record.url?scp=85013124674&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85013124674&partnerID=8YFLogxK
U2 - 10.4082/kjfm.2017.38.1.40
DO - 10.4082/kjfm.2017.38.1.40
M3 - Article
VL - 38
SP - 40
EP - 42
JO - Korean Journal of Family Medicine
JF - Korean Journal of Family Medicine
SN - 2005-6443
IS - 1
ER -